Antigenicity of recombinant proteins derived from Plasmodium falciparum merozoite surface protein 1

Molecular and Biochemical Parasitology

Volumn 85, Issue 2, 1997, Pages 197-211

  Cavanagh, David R ^a   McBride, Jana S ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

antibody; malaria; Plasmodium falciparum; recombinant antigens

Indexed keywords

MALARIA VACCINE; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGENICITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; MEROZOITE; MOLECULAR CLONING; MOUSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ALLELES; AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, PROTOZOAN; AOTUS TRIVIRGATUS; HUMANS; IMMUNE SERA; IMMUNOGLOBULIN G; MEROZOITE SURFACE PROTEIN 1; MICE; MOLECULAR SEQUENCE DATA; PLASMODIUM FALCIPARUM; PROTEIN BINDING; PROTEIN PRECURSORS; PROTOZOAN PROTEINS; RECOMBINANT FUSION PROTEINS; SAIMIRI;

EID: 0030890001     PISSN: 01666851     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-6851(96)02826-5     Document Type: Article

References (47)

1. Howard R.J., Pasloske B.L. Target antigens for asexual malaria vaccine development. Parasitol. Today. 9:1993;369-374.
2. Holder A.A., Freeman R.R. The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor. J. Exp. Med. 160:1984;624-629.
3. McBride J.S., Heidrich H-G. Fragments of the polymorphic Mr 185 000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex. Mol. Biochem. Parasitol. 23:1987;71-84.
4. Holder A.A., Sandhu J.S., Hillman Y., Davey L.S., Nicholls S.C., Cooper H., Lockyer M.J. Processing of the precursor to the major merozoite surface antigens of Plasmodium falciparum. Parasitology. 94:1987;199-208.
5. Lyon J.A., Geller R.H., Haynes D., Chulay J.D., Weir J.L. Epitope map and processing scheme for the 195 000-dalton surface glycoprotein of Plasmodium falciparum merozoites deduced from cloned overlapping segments of the gene. Proc. Natl. Acad. Sci. USA. 83:1986;2989-2993.
6. Blackman M.J., Heidrich H-G., Donachie S., McBride J.S., Holder A.A. A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies. J. Exp. Med. 172:1990;379-382.
7. Holder A.A., Lockyer M.J., Odink K.G., Sandhu J.S., Riveros-Moreno V., Nicholls S.C., Hillman Y., Davey L.S., Tizard M.L.V., Schwarz R.T., Freeman R.R. Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites. Nature. 317:1985;270-273.
8. 33 as a noncovalently associated complex with other fragments of MSP-1. Mol. Biochem. Parasitol. 50:1992;307-316.
9. Tanabe K., MacKay M., Goman M., Scaife J.G. Allelic dimorphism in a surface antigen of the malaria parasite Plasmodium falciparum. J. Mol. Biol. 195:1987;273-287.
10. Miller L.H., Roberts T., Shahabuddin M., McCutchan T.F. Analysis of sequence diversity in the Plasmodium falciparum merozoite protein-1 (MSP-1). Mol. Biochem. Parasitol. 59:1993;1-14.
11. Conway D.J., Greenwood B.M., McBride J.S. Longitudinal study of Plasmodium falciparum polymorphic antigens in a malaria-endemic population. Infect. Immun. 60:1992;1122-1127.
12. McBride J.S., Newbold C.I., Anand R. Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum. J. Exp. Med. 161:1985;160-180.
13. Siddiqui W.A., Tam L.Q., Kramer K.J., Hui G.S., Yamaga K.M., Chang S.P., Chan E.B., Kan S.C. Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria. Proc. Natl. Acad. Sci. USA. 84:1987;3014-3018.
14. Hall R., Hyde J.E., Goman M., Simmons D.L., Hope I.A., Mackay M., Merkli B., Richle R., Stocker J. Major surface antigen of a human malaria parasite cloned and expressed in bacteria. Nature. 311:1984;379-385.
15. Etlinger H.M., Caspers P., Matile H., Schoenfield H.-J., Stueber D., Takacs B. Ability of recombinant or native proteins to protect monkeys against heterologous challenge with Plasmodium falciparum. Infect. Immun. 59:1991;3498-3503.
16. Holder A.A., Freeman R.R., Nicholls S.C. Immunisation against Plasmodium falciparum with recombinant polypeptides produced in Escherichia coli. Parasite Immunol. 10:1988;607-617.
17. Herrera M.A., Rosero F., Herrera S., Caspers P., Rotmann D., Sinigaglia F., Certa U. Protection against malaria in Aotus monkeys immunised with a recombinant blood stage antigen fused to a universal T-cell epitope: Correlation of serum gamma interferon levels with protection. Infect. Immun. 60:1992;154-158.
18. Kumar S., Yadava A., Keister D.B., Tian J.H., Ohl M., Perdue-Greenfield K.A., Miller L.H., Kaslow D.C. Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys. Mol. Med. 1:1995;325-332.
19. Chang S.P., Case S.E., Gosnell W.L., Hashimoto A., Kramer K.J., Tam L.Q., Hashiro C.Q., Nikaido C.M., Gibson H.L., Lee-Ng C.T., Barr P.J., Yokota B.T., Hui G.S. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite protein 1 protects Aotus monkeys against malaria. Infect. Immun. 64:1996;253-261.
20. Holder A.A., Riley E.M. Human immune response to MSP-1. Parasitol. Today. 12:1996;173-174.
21. Patarroyo M.E., Amador R., Clavijo P., Moreno A., Guzman F., Romero P., Tascon R., Franco A., Murillo L.A., Ponton G., Trujillo G. A synthetic vaccine protects humans against challenge with asexual blood stages of Plasmodium falciparum malaria. Nature. 332:1988;158-161.
22. Amador R., Moreno A., Valero V., Murillo L., Mora A., Rojas M., Rocha C., Salcedo M., Guzman F., Espejo F., Nunez F., Patarroyo M. The first field trials of the chemically synthesised malaria vaccine SPf66: safety, immunogenicity and protectivity. Vaccine. 10:1988;179-184.
23. Alessandro U.D., Leach A., Drakeley C.J., Bennett S., Olaleye B.O., Fegan G.W., Jawara M., Langerock P., George M.O., Targett G.A.T., Greenwood B.M. Efficacy trial of malaria vaccine SPf66 in Gambian children. Lancet. 346:1995;462-467.
24. Locher C.P., Tam L.Q., Chang S.P., McBride J.S., Siddiqui W.A. Plasmodium falciparum: gp195 tripeptide repeat-specific monoclonal antibody inhibits parasite growth in vitro. Exp. Parasitol. 84:1996;74-83.
25. Müller H-M., Früh K., von Brunn A., Esposito F., Lombardi S., Crisanti A., Bujard H. Development of the human immune response against the major surface protein (gp190) of Plasmodium falciparum. Infect. Immun. 57:1989;3765-3769.
26. Früh K., Doumbo O., Müller H-M., Koita O., McBride J., Crisanti A., Touré Y., Bujard H. Human antibody response to the major merozoite surface antigen of Plasmodium falciparum is strain specific and short lived. Infect. Immun. 59:1991;1319-1324.
27. Chizzolini C., Dupont A., Akue J.P., Kaufman M.H., Verdini A.S., Pessi A., Del Giudice G. Natural antibodies against three distinct and defined antigens of Plasmodium falciparum in residents of a mesoendemic area in Gabon. Am. J. Trop. Med. Hyg. 39:1988;150-156.
28. Tolle R., Früh K., Doumbo O., Koita O., N'Diaye M., Fischer A., Dietz K., Bujard H. A prospective study of the association between human humoral immune response to Plasmodium falciparum blood stage antigen gp190 and control of malaria infections. Infect. Immun. 61:1993;40-47.
29. Walliker D., Quakyi I.A., Wellems T.E., McCutchan T.F., Szarfman A., London W.T., Corcoran L.M., Burkot T.R., Carter R. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science. 236:1987;1661-1666.
30. Chang S.P., Kramer K.J., Yamaga K.M., Kato A., Case S.E., Siddiqui W.A. Plasmodium falciparum: gene structure and hydropathy profile of the major merozoite surface antigen (gp195) of the Uganda-Palo Alto isolate. Exp. Parasitol. 67:1988;1-11.
31. Certa U., Rotmann D., Matile H., Reber-Liske R. A naturally occurring gene encoding the major surface antigen precursor P190 of Plasmodium falciparum lacks tripeptide repeats. EMBO J. 6:1987;4137-4142.
32. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science. 193:1976;673-675.
33. Haynes J.D., Diggs C.L., Hines F.A., Desjardins R.E. Culture of the human malaria parasite Plasmodium falciparum. Nature. 263:1976;767-769.
34. Fenton B., Clark J.T., Khan C.M.A., Robinson V.J., Walliker D., Ridley R., Scaife J.G., McBride J.S. Structure and antigenic polymorphism of the 35- to 48- kilodalton merozoite surface antigen (MSA-2) of the malaria parasite Plasmodium falciparum. Mol. Cell. Biol. 11:1991;963-971.
35. Smith D.B., Johnson K.S. Single step purification of polypeptides expressed in E. coli as fusions with glutathione S-transferase. Gene. 67:1988;31-40.
36. Sambrook J., Fritsch E.F., Maniatis T. 2nd edition Molecular Cloning: A laboratory manual. 1989;Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
37. Burghaus P.A., Holder A.A. Expression of the 19kDa carboxy-terminal fragment of Plasmodium falciparum merozoite surface protein-1 in Escherichia coli as a correctly folded protein. Mol. Biochem. Parasitol. 64:1994;165-169.
38. Conway D.J., McBride J.S. Population genetics of Plasmodium falciparum within a malaria hyperendemic area. Parasitology. 103:1991;7-16.
39. Hawkes R. Identification of concavalin A-binding proteins after sodium dodecyl suphate gel electrophoresis and protein blotting. Anal. Biochem. 123:1982;143-146.
40. Ranford-Cartwright L.C., Balfe P., Carter R., Walliker D. Direct sequencing of enzymatically-amplified DNA of alleles of the merozoite protein MSA-1 gene from the malaria parasite Plasmodium falciparum. Mol. Biochem. Parasitol. 46:1991;185-188.
41. Peterson M.G., Coppel R.G., McIntyre P., Langford C.J., Woodrow G., Borwn G.V., Anders R.F., Kemp D.J. Variation in the precursor to the major merozoite surface antigens of Plasmodium falciparum. Mol. Biochem. Parasitol. 27:1988;291-302.
42. Anders R.F. Multiple cross-reactivities amongst antigens of Plasmodium falciparum impair the development of protective immunity against malaria. Parasite Immunol. 8:1986;529-539.
43. Fuchs S., Mozes E., Maoz A., Sela M. Thymus independence of a collagen-like synthetic polypeptide and of collagen and need for thymus and bone marrow cell cooperation in immune response to gelatin. J. Exp. Med. 139:1974;148-158.
44. Hillman K., Shapira-Nahor O., Blackburn R., Hernandez D., Golding H. A polymer containing a repeating peptide sequence can stimulate T-cell independent IgG antibody production in vivo. Cell Immuno. 134:1991;1-13.
45. Kemp D.J., Coppel R.L., Anders R.F. Repetitive proteins and genes of malaria. Annu. Rev. Microbiol. 41:1987;181-208.
46. Schofield L. On the function of repetitive domains in protein antigens of Plasmodium and other eukaryotic parasites. Parasitol. Today. 7:1991;99-105.
47. Holder A.A., Blackman M.J., Burhaus P.A., Chappel J.A., Ling I.T., McCallum-Deighton N., Shai S. A malaria merozoite surface protein (MSP-1)-structure, processing and function. 87:1992;37-42 Mem. Inst. Oswaldo. Cruz.